James L. Tyree

Companies

• GENELUX CorpBoard member Jan 25, 2023 to now¹
• Assertio Holdings, Inc.Board member May 21, 2020 to Mar 15, 2024²
• ChemoCentryx, Inc.Board member Jun 7, 2012 to Oct 24, 2022³
• Innoviva, Inc.Board member Jun 4, 2014 to Apr 24, 2017⁴
• Abbott LaboratoriesSenior Vice President May 2, 2005 to Mar 3, 2009⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Abbott Laboratories ABT133,375 shares⁶$14.0M at $104.71Mar 3, 2009
• GGENELUX Corp GNLX96,483 shares⁷$237.8K at $2.47Jun 16, 2026
• CChemoCentryx, Inc.0 shares⁸Oct 20, 2022
• AAssertio Holdings, Inc.188,251 shares⁹Mar 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 16, 2026Granted 28,409 shares of GENELUX Corp⁷
• Aug 27, 2025Granted 22,283 shares of GENELUX Corp¹⁰
• Dec 30, 2024Sold 3,460 shares at $2.46 of GENELUX Corp¹¹
• Sep 11, 2024Sold 1,730 shares at $2.60 of GENELUX Corp¹²
• Aug 1, 2024Granted 39,541 shares of GENELUX Corp¹³
• May 29, 2024Bought 6,250 shares of GENELUX Corp¹⁴
• Mar 14, 2024Sold 10,251 shares at $1.12 of Assertio Holdings, Inc.⁹
• Dec 13, 2023Sold 3,347 shares at $13.73 of GENELUX Corp¹⁵
• Dec 13, 2023Sold 5,653 shares at $12.91 of GENELUX Corp¹⁵
• Sep 11, 2023Granted 3,460 shares of GENELUX Corp¹⁶
• May 10, 2023Granted 31,194 shares of Assertio Holdings, Inc.¹⁷
• May 5, 2023Sold 43,143 shares at $6.00 of Assertio Holdings, Inc.¹⁸
• Feb 17, 2023Granted 9,000 shares of GENELUX Corp¹⁹
• Oct 20, 2022Returned to company 9,138 shares of ChemoCentryx, Inc.⁸
• Aug 4, 2022Sold 10,000 shares at $50.22 of ChemoCentryx, Inc.²⁰
• Jun 9, 2022Sold 59 shares at $26.22 of ChemoCentryx, Inc.²¹
• Jun 9, 2022Sold 3,804 shares at $25.65 of ChemoCentryx, Inc.²¹
• May 20, 2022Exercised options 7,726 shares of ChemoCentryx, Inc.²²
• May 12, 2022Sold 44,643 shares at $2.36 of Assertio Holdings, Inc.²³
• May 4, 2022Granted 86,286 shares of Assertio Holdings, Inc.²⁴
• Dec 17, 2021Sold 18,066 shares at $35.50 of ChemoCentryx, Inc.²⁵
• Dec 17, 2021Sold 16,634 shares at $34.74 of ChemoCentryx, Inc.²⁵
• Dec 17, 2021Sold 2,800 shares at $33.52 of ChemoCentryx, Inc.²⁵
• Dec 17, 2021Exercised options 12,500 shares at $14.42 of ChemoCentryx, Inc.²⁵
• Dec 17, 2021Exercised options 25,000 shares at $12.62 of ChemoCentryx, Inc.²⁵